AUTL
$2.85
Autolus Therapeutics Plc ADR
($.10)
(3.39%)
AUTL
Earnings Whisper ®
N/A
2nd Quarter June 2023
Consensus: ($0.22)
Revenue: $0.10 Mil
Latest EPS
Thursday, May 4, 2023
What do you expect when AUTL reports earnings?
Where is AUTL's stock price going from here?
Analysts
Pivots
Resistance
$3.16
$3.07
$3.01
Support
$2.87
$2.78
$2.72
Description
Autolus Therapeutics plc is a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies. The company's pipeline of product candidate involved in development for the treatment of haematological malignancies and solid tumours. Autolus Therapeutics plc is based in London, United Kingdom.
